23 May 2013
Keywords: Roche, Zelboraf, EMA, Daiichi Sankyo, Metastatic melanoma
Article | 19 December 2011
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the granting of a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 December 2011
20 December 2011
© 2013 thepharmaletter.com